Epigenetics, MicroRNAs and Non Coding RNAs in Disease: Market Analysis, Size, Share, Industry Growth, Trends and Forecast Research Report by ResearchMoz.us
Albany, NY (PRWEB) July 31, 2013 -- ResearchMoz presents this most up-to-date research on Epigenetic and MicroRNA Biomarkers 2013 Market Report. The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Epigenetic and MicroRNA Biomarkers Market.
The epigenetic and microRNA biomarkers fields are co-evolving and have reached a critical point wherein enough signatures have been identified across various different disease classes, most notably in cancer, that some of these signatures/expression patterns can be validated and deployed for use in the clinic. However, these biomarker fields are evolving in parallel with the research marketplace, and therefore SELECTBIO has in this market report characterized the research markets for both these fields so as to present a comprehensive analysis that en bloc provides a complete picture of this expanding marketplace.
View Full Report With TOC@ http://www.researchmoz.us/epigenetic-and-microrna-biomarkers-2013-market-report-report.html
Specific Topics Addressed in this Market Report:
Epigenetics Research Market Analysis
Primary Market Survey to Characterize Research Market Trends based on Data Collected from Researchers
Breakout of Epigenetics Research Activity based on Epigenetic Modifications Studied
Segmentation of Epigenetics Research Activity based on Disease Classes Studied
Epigenetics Research Activity in Cancer--Quantitative Segmentation
Reagent Kits and Products in the Epigenetics Research Field [Details of Products from the Vendors in this Space are Presented and Analyzed]
Epigenetics Biomarkers
En masse Analysis of All Epigenetics-focused Publications and Trends from these Data with respect to Potential Epigenetics Biomarkers
Description of Epigenetic Biomarkers Identified to Date in Various Cancer Classes [Nature of Epigenetic Signature, Potential Role in Prognostics and Diagnostics]
MicroRNA Research Market Analysis
Primary Market Survey Data Presents a Complete Picture of the microRNA Research Field based on End-User/Researcher Practices
Methodologies and Market Breakout for Expression Profiling
Quantitative Breakout of the microRNA Research Market Across the Research Workflow
Product Vendors and their Quantitative Penetrance in the microRNA Research Markets
Browse All Select Biosciences Market Research Reports- http://www.researchmoz.us/publisher/select-biosciences-38.html
MicroRNA Biomarkers Analysis
Expression Patterns/Signatures of microRNAs in Different Disease States
Prognostic/Diagnostic Potential of microRNA Expression Patterns
microRNAs in Biological Fluids as Circulating Biomarkers: List and Significance
Cancer Biomarker Classes
Traditional Cancer Biomarkers
Oncogenes
Tumor-Suppressor Genes
Companion Diagnostics (CDx)
Up-to-date List of CDx on the Marketplace
Partnerships in the CDx Space
Table Of Contents
Chapter I. Epigenetics Research Market Analysis
Primary Market Survey to Characterize Marketplace from the
Bottom-Up: Qualitative and Quantitative Market Data
Current Research Paradigms
Quantitative Segmentation of Epigenetics Research
Epigenetics Research in Cancer: Quantitative Segmentation
Commercial Kit and Reagent Offerings in the Epigenetics
Research Marketplace
Chapter II. Epigenetic Signatures as Potential Biomarkers
Big Data Analysis of Epigenetics Publication Landscape
Hotspot Analysis of Publications Describes Segments of Opportunity vis-à-vis Research Product Development as well as Potential Assay Development for Disease Associations, Harvesting of Prognostic as well as Diagnostic Biomarkers
Epigenetic Signatures Described in Various Disease Classes
DNA Methylation as Disease Biomarkers
Histone Modifications as Disease Biomarkers
Potential Epigenetic Biomarkers in Various Cancer Classes
Gastric Cancer
Pancreatic Cancer
Prostate Cancer
Chapter III. microRNA Research Market Analysis
Related Report - Mass Spectrometry for Clinical Diagnostics Applications 2013 (http://www.researchmoz.us/mass-spectrometry-for-clinical-diagnostics-applications-2013-focus-report-report.html)
microRNA Signatures as Potential Biomarkers
Prima y Market Survey to Characterize Marketplace from the
Bottom-Up: Qualitative and Quantitative Market Data
microRNA Research vis-à-vis Content Classes
microRNA Research in Cancer
microRNA Research Workflow: Quantitative Breakout
microRNA Expression Profiling Quantitative Market Breakout
microRNA Vendor Market Penetration Space Map
NGS to Study microRNAs—Market Breakout by Platform
Unmet Needs in the microRNA Research Space
microRNA Signatures Described in Various Disease Classes:
Potential for Biomarker Development
Tumor Suppressor microRNA Methylation
microRNAs in Biofluids
Circulating microRNAs as Potential Tumor Markers
Chapter IV. Characterization of Molecular Biomarker Classes
Traditional Cancer Biomarkers
Oncogenes
Tumor Suppressor Genes
Appendix I. Epigenetic and MicroRNA Biomarker Summary
Appendix II. List of Companion Diagnostics (CDx) on the Market, In Progress CDx in Development/Partnerships, Potential Market Size for Epigenetic and microRNA-based CDx
Appendix III. Research Methodology
#####
Browse Latest Published Reports-
Cellular Therapy and Cord Blood 2013
(http://www.researchmoz.us/cellular-therapy-and-cord-blood-report.html)
In this comprehensive market report, we have focused primarily on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field--in this vein, we present primary industry data that Select Biosciences has collected as part of its continual industry tracking of this space. We've analyzed clinical trial trends and the evolution of several therapeutics areas within cellular therapy [orthopedic, skin/wound care, cardiovascular, and CNS disorders] and present the current status of every single program within the preclinical through the various clinical trial phases and onto commercialization.
Global Personalized Medicine Diagnostics Market
(http://www.researchmoz.us/global-personalized-medicine-diagnostics-market-2012-2016-report.html)
Global Personalized Medicine Diagnostics market to grow at a CAGR of 4.43 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for personalized medicine for treating cancer. The Global Personalized Medicine Diagnostics market has also been witnessing an increase in the number of industrial activities. However, the low awareness of personalized medicine diagnostics in developing countries could pose a challenge to the growth of this market. Global Personalized Medicine Diagnostics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts.
About Us:
ResearchMoz ( http://www.researchmoz.us/ ) is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.
For More Information Kindly Contact:
Email: sales(at)researchmoz(dot)us
Browse Blog - http://marketing-strategies-topics.blogspot.com/
Michell Thoras, ResearchMoz, http://www.researchmoz.us/, +1-518-618-1030, [email protected]
Share this article